diabetes
Conditions
Interventions
treatment group:Take Dapagliflozin tablets.
control group:Take epalrestat tablets
Sponsors
Nanjing Integrated Traditional Chinese and Western Medicine Hospital Affiliated with Nanjing University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Type 2 diabetes patients diagnosed with DPN; The drugs related to DPN have not been adjusted within three months. SNAP < 6µV or nerve conduction velocity < 42 m/s; Fibular SNAP< 10µV, fibular NLG < 42 m/s, tibial MNAP < 8 mV, tibial MNLG < 40 m/s; No history of acupuncture treatment for peripheral neuropathy; Aged 18 to 65.
Exclusion criteria
Exclusion criteria: BMI > 35 kg/m^²; PN not caused by diabetes (such as alcohol abuse, chemotherapy, genetic reasons, chronic inflammation or idiopathic PN, etc.); History of epilepsy Coagulation dysfunction or bleeding accompanied by the use of anticoagulants; There are bacterial infections or other skin diseases in the lower extremities that hinder acupuncture treatment; Lower limb fractures within the last three months; Have received acupuncture treatment within the last three months; I am currently participating in other clinical studies.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| DPN symptom score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Nerve conduction velocity;ABI;Effect of sweat secretion function;dynamic balance; | — |
Countries
China
Contacts
Public ContactZhang yongwen
Nanjing Integrated Traditional Chinese and Western Medicine Hospital Affiliated with Nanjing University of Chinese Medicine
Outcome results
None listed